| GR00053-A |
6176 |
NM_001003 |
RPLP1 |
np |
sp |
none |
|
no |
|
Genome stability |
A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. |
Paulsen et al. |
2009 |
19647519 |
Cell line |
HeLa |
gamma-H2AX phosphorylation and DNA content |
Fluorescence |
siARRAY human genome siRNA library |
Genome-wide |
siRNA |
p-value |
Complex criteria |
Confidence groupings from 4 to 1 (highest level of confidence in group 4) |
GR00054-A |
6176 |
NM_001003 |
RPLP1 |
np |
0.987 |
none |
|
no |
|
Combinatorial effect with paclitaxel |
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. |
Whitehurst et al. |
2007 |
17429401 |
Cell line |
NCI-H1155 |
Viability (synthetic lethal) |
ATP level |
# G-005000-01 |
Genome-wide |
siRNA |
Paclitaxel/control ratio |
Complex criteria |
Additional information about 87 high-confidence hits |
GR00056-A |
6176 |
NM_001003 |
RPLP1 |
np |
0.887 |
none |
|
no |
|
Melanogenesis |
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. |
Ganesan et al. |
2008 |
19057677 |
Cell line |
MNT-1 |
Melanin protein expression and viability |
Absorbance and luminescence |
rp |
Genome-wide |
siRNA |
Normalized absorbance ratio |
> 2 standard deviations below mean |
Additional information about a secondary screen (retest to determine false-positive rate) |
GR00057-A-1 |
6176 |
NM_001003 |
RPLP1 |
M-011135-00 |
-1.06 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (1) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Z-score |
> 4 |
Screen without Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00057-A-2 |
6176 |
NM_001003 |
RPLP1 |
M-011135-00 |
sp |
none |
|
yes |
excluded from hits: Reagent targets ribosomal gene |
Wnt/beta-catenin pathway regulation (2) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Complex, SP |
Complex criteria |
Screen with Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00098-A-1 |
6176 |
ENSG00000137818 |
RPLP1 |
ENSG00000137818 |
sp |
Increased S DNA content, increased G2M DNA content |
|
yes |
S arrest, validated with resynthesized esiRNA |
Cell division (1) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Cell number and DNA content |
Laser scanning cytometry |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00098-A-3 |
6176 |
ENSG00000137818 |
RPLP1 |
ENSG00000137818 |
-3.6 |
none |
|
yes |
|
Cell division (3) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Histone H3 phosphorylation; alpha-tubulin and pericentrin protein expression |
Fluorescence |
rp |
Selected genes |
esiRNA |
Mitotic index |
> |
|
GR00098-A-4 |
6176 |
ENSG00000137818 |
RPLP1 |
ENSG00000137818 |
-1.1 |
none |
|
no |
|
Cell division (4) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Cell size (forward scatter) |
Flow cytometry |
rp |
Selected genes |
esiRNA |
Cell size |
> |
|
GR00151-A-1 |
6176 |
ENSG00000137818 |
RPLP1 |
np |
-1.719 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. |
Słabicki et al. |
2010 |
20613862 |
Cell line |
HeLa |
(HR-DSBR) DR-GFP reporter |
Flow cytometry |
Custom-made |
Genome-wide |
esiRNA |
Z-score |
< -2 OR > 2 |
|
GR00180-A-1 |
6176 |
6176 |
RPLP1 |
PL-50050 |
0.805 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00184-A-1 |
6176 |
NM_001003 |
RPLP1 |
M-011135-00 |
1.31428619114441 |
none |
|
no |
|
Self-renewal and pluripotency in human embryonic stem cells (1) |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. |
Chia et al. |
2010 |
20953172 |
Cell line |
hESC H1 |
POU5F1 protein expression |
Fluorescence |
SMARTpool siRNA library |
Genome-wide |
siRNA |
Z-score |
< -2 |
|
GR00196-A-1 |
6176 |
ENSG00000137818 |
|
np |
sp |
Decreased viability of wild-type and TP53 knockout cells |
|
no |
viability Z-score < -1.5 |
TP53 interactions (1) |
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. |
Krastev et al. |
2011 |
21642980 |
Cell line |
HCT116 ( wildtype and TP53 knockout) |
TP53 protein expression and viability |
Fluorescence |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00197-A-1 |
6176 |
6176 |
RPLP1 |
M-011135-00 |
-1.862720768 |
none |
|
no |
|
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00209-A-1 |
6176 |
NM_001003, NM_213725 |
RPLP1 |
np |
0.67 |
Nucleolar pre-40S maturation defects |
|
yes |
10 nM siRNA; ratio nucleoplasmic/total hit classified cells: 0.0826945 |
Ribosome biogenesis (1) |
A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. |
Wild et al. |
2010 |
21048991 |
Cell line |
HeLa |
Rps2 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
Average relative rank from > |
> 0.2 |
|
GR00209-A-2 |
6176 |
NM_001003, NM_213725 |
RPLP1 |
np |
sp |
Nuclear 40S maturation defects |
|
yes |
|
Ribosome biogenesis (2) |
A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. |
Wild et al. |
2010 |
21048991 |
Cell line |
HeLa |
Enp1 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
|
GR00209-A-3 |
6176 |
NM_001003, NM_213725 |
RPLP1 |
np |
0.38 |
Nuclear 60S biogenesis defects |
|
no |
|
Ribosome biogenesis (3) |
A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. |
Wild et al. |
2010 |
21048991 |
Cell line |
HeLa |
Rpl29 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
Average relative rank from > |
> 0.25 |
|
GR00232-A-1 |
6176 |
NM_001003 |
RPLP1 |
v2HS_143168 |
1.010372837 |
Decreased ionizing radiation sensitivity |
|
no |
|
DNA damage regulation after ionizing radiation (1) |
A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. |
Hurov et al. |
2010 |
20810650 |
Cell line |
U2OS |
Ionizing radiation sensitivity |
Fluorescence |
pSMP |
Genome-wide |
shRNA |
log2 mean ratio |
< -1 OR > 1 |
The shRNA library is in a MSCV-PURO-based vector (MSCV-PM; Open Biosystems nomenclature is pSMP). The shRNAs with the “V3LHS†identifier were subcloned into the MSCV-PM vector from the pGIPZ vector. Additional information about a secondary screen in H460 cells. |
GR00236-A-1 |
6176 |
6176 |
RPLP1 |
M-011135-00 |
1.27369176259159 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00240-S-1 |
6176 |
NM_001003 |
RPLP1 |
M-011135-00 |
5.92 |
Decreased viability |
|
yes |
|
TRAIL-induced apoptosis (1) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Z-score |
> 4 |
Author-submitted data |
GR00240-S-2 |
6176 |
NM_001003 |
RPLP1 |
M-011135-00 |
np |
none |
|
no |
Z-score 3.296; viability Z-score > 4 |
TRAIL-induced apoptosis (2) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability (synthetic lethal) |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Differential score |
> 3.6 AND viability Z-score < 4 |
Author-submitted data. Z-scores from viability screen (1) are considered in score interpretation for this screen. |
GR00242-A-1 |
6176 |
NM_001003 |
RPLP1 |
np |
sp |
none |
|
no |
|
Selective autophagy regulation (1) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
siGenome |
Genome-wide |
siRNA |
Z-score |
Complex criteria |
|
GR00247-A-1 |
6176 |
|
RPLP1 |
np |
sp |
none |
|
|
rank: 781 |
Regulation of FOXO1 nuclear localization (1) |
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. |
Senapedis et al. |
2011 |
21460183 |
Cell line |
U2OS |
EGFP-FOXO1a protein expression and DNA content |
Fluorescence |
Human Genome library |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
|
GR00249-S |
6176 |
6176 |
RPLP1 |
s12239 |
-2.60093 |
Decreased vaccinia virus (VACV) infection |
|
no |
number of cells compared to control (%): 59.07 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6176 |
6176 |
RPLP1 |
s194758 |
-2.84812 |
Decreased vaccinia virus (VACV) infection |
|
no |
number of cells compared to control (%): 57.03 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6176 |
6176 |
RPLP1 |
s194759 |
-2.85539 |
Decreased vaccinia virus (VACV) infection |
|
no |
number of cells compared to control (%): 53.49 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00253-A |
6176 |
NM_001003 |
RPLP1 |
np |
-3.32 |
Decreased hepcidin::fluc mRNA expression |
|
|
|
hepcidin regulation |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. |
Mleczko-Sanecka et al. |
2014 |
24385536 |
Cell line |
Huh7 |
hepcidin::fluc mRNA expression |
Luminescence |
siGenome siARRAY SMARTpool |
Genome-wide |
siRNA |
Z-score |
> |
Cutoff < |
GR00255-A-1 |
6176 |
6176 |
RPLP1 |
TRCN0000117522, TRCN0000117523, TRCN0000117524, TRCN0000117525, TRCN0000117526 |
1.203212245 |
none |
|
|
|
Negative genetic interactions (1) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-2 |
6176 |
6176 |
RPLP1 |
TRCN0000117522, TRCN0000117523, TRCN0000117524, TRCN0000117525, TRCN0000117526 |
-0.117016929 |
none |
|
|
|
Negative genetic interactions (2) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-3 |
6176 |
6176 |
RPLP1 |
TRCN0000117522, TRCN0000117523, TRCN0000117524, TRCN0000117525, TRCN0000117526 |
-0.842811289 |
none |
|
|
|
Negative genetic interactions (3) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-4 |
6176 |
6176 |
RPLP1 |
TRCN0000117522, TRCN0000117523, TRCN0000117524, TRCN0000117525, TRCN0000117526 |
2.516638572 |
none |
|
|
|
Negative genetic interactions (4) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-5 |
6176 |
6176 |
RPLP1 |
TRCN0000117522, TRCN0000117523, TRCN0000117524, TRCN0000117525, TRCN0000117526 |
-0.609732913 |
none |
|
|
|
Negative genetic interactions (5) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -0.8 |
HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00706825 |
1 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00706811 |
2 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00584857 |
2 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00706832 |
1 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00584843 |
1 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00584836 |
2 |
Decreased centriole number |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00290-A |
6176 |
6176 |
RPLP1 |
SI00706818 |
0 |
none |
|
|
|
Centriole biogenesis |
Discovering Regulators of Centriole Biogenesis through siRNA-Based Functional Genomics in Human Cells |
Balestra et al. |
2013 |
23769972 |
Cell line |
HeLa |
Centriole number |
Fluorescence |
Qiagen |
Genome-wide |
siRNA |
Phenotype strength |
0: none, 1: weak, 2: clear, 3: strong |
For alternative scores (RSA and Top2) see publication. |
GR00293-A |
6176 |
|
RPLP1 |
np |
0.44 |
none |
|
|
|
Combinatorial effect with paclitaxel |
Mechanisms Promoting Escape from Mitotic Stress−Induced Tumor Cell Death |
Sinnott et al. |
2014 |
24860162 |
Cell line |
HCC366 |
Viability |
Luminescence |
Thermo-Fisher |
Genome-wide |
siRNA |
Z-score |
< -2.5 |
Final hits according to the author are indicated in the comment. |
GR00300-A |
6176 |
|
RPLP1 |
TRCN0000117524, TRCN0000117523, TRCN0000117526, TRCN0000117525, TRCN0000117522 |
0 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
GR00303-A |
6176 |
NM_001003 |
RPLP1 |
np |
-2.71 |
none |
|
|
|
Clear cell renal cell carcinoma (ccRCC) survival regulation |
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
Gerlinger et al. |
2012 |
22362593 |
Cell line |
VHL-deficient RCC4 |
Proliferation and Viability |
Fluorescence |
np |
Genome-wide |
siRNA |
Z-score |
< |
In the phenotype data duplicates were in the original document, which have been removed. |
GR00313-A |
6176 |
NM_001003 |
RPLP1 |
np |
-2.31 |
none |
|
|
|
TNF-alpha pathway regulation |
A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. |
Nickles et al. |
2012 |
22733992 |
Cell line |
HEK293T |
NFkappaB pathway reporter |
Luminescence |
Qiagen |
Genome-wide |
siRNA |
Z-score |
< |
Additional filters were a reduction in firefly luciferase levels by at least 50% compared to the mean of the experiment and a concomitant reduction of renilla luciferase expression of not more than 30%. |
|
6176 |
6176 |
RPLP1 |
|
-0.16999999999999998 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00376-A-1 |
6176 |
6176 |
RPLP1 |
|
0.926236325 |
none |
|
|
|
Mitigators of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID |
GR00376-A-2 |
6176 |
6176 |
RPLP1 |
|
8.53477E-5 |
Decreased viability with SS1P at EC30 |
|
|
|
Sensitizers of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID |
|
6176 |
NM_001003 |
RPLP1 |
|
20.491 |
Decreased viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|